Literature DB >> 26670609

A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Matthew S J Mangan1, Catherina H Bird1, Dion Kaiserman1, Anthony Y Matthews1, Corinne Hitchen1, David L Steer1, Philip E Thompson2, Phillip I Bird3.   

Abstract

The intracellular protease inhibitor Sb9 (SerpinB9) is a regulator of the cytotoxic lymphocyte protease GzmB (granzyme B). Although GzmB is primarily involved in the destruction of compromised cells, recent evidence suggests that it is also involved in lysosome-mediated death of the cytotoxic lymphocyte itself. Sb9 protects the cell from GzmB released from lysosomes into the cytosol. Here we show that reactive oxygen species (ROS) generated within cytotoxic lymphocytes by receptor stimulation are required for lyososomal permeabilization and release of GzmB into the cytosol. Importantly, ROS also inactivate Sb9 by oxidizing a highly conserved cysteine pair (P1-P1' in rodents and P1'-P2' in other mammals) in the reactive center loop to form a vicinal disulfide bond. Replacement of the P4-P3' reactive center loop residues of the prototype serpin, SERPINA1, with the P4-P5' residues of Sb9 containing the cysteine pair is sufficient to convert SERPINA1 into a ROS-sensitive GzmB inhibitor. Conversion of the cysteine pair to serines in either human or mouse Sb9 results in a functional serpin that inhibits GzmB and resists ROS inactivation. We conclude that ROS sensitivity of Sb9 allows the threshold for GzmB-mediated suicide to be lowered, as part of a conserved post-translational homeostatic mechanism regulating lymphocyte numbers or activity. It follows, for example, that antioxidants may improve NK cell viability in adoptive immunotherapy applications by stabilizing Sb9.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  SerpinB9; T cell; granzyme B; immunotherapy; lysosomal membrane permeabilization; lysosome; natural killer cells (NK cells); protease; reactive oxygen species (ROS); serpin

Mesh:

Substances:

Year:  2015        PMID: 26670609      PMCID: PMC4751400          DOI: 10.1074/jbc.M115.699298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.

Authors:  Inna S Afonina; Sean P Cullen; Seamus J Martin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Regulation of T-cell apoptosis by reactive oxygen species.

Authors:  David A Hildeman
Journal:  Free Radic Biol Med       Date:  2004-06-15       Impact factor: 7.376

3.  Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.

Authors:  Alfons S K de Hooge; Dagmar Berghuis; Susy Justo Santos; Esther Mooiman; Salvatore Romeo; J Alain Kummer; R Maarten Egeler; Maarten J D van Tol; Cornelis J M Melief; Pancras C W Hogendoorn; Arjan C Lankester
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

4.  Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage.

Authors:  A Wahid Ansari; Jeff N Temblay; Syarifah H Alyahya; Philip G Ashton-Rickardt
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

5.  Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites.

Authors:  M Hansson; A Asea; U Ersson; S Hermodsson; K Hellstrand
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

6.  Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.

Authors:  J P Medema; J de Jong; L T Peltenburg; E M Verdegaal; A Gorter; S A Bres; K L Franken; M Hahne; J P Albar; C J Melief; R Offringa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

Review 7.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

8.  The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.

Authors:  Claire E Hirst; Marguerite S Buzza; Catherina H Bird; Hilary S Warren; Paul U Cameron; Manling Zhang; Philip G Ashton-Rickardt; Phillip I Bird
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

9.  Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

Authors:  J Loebbermann; H Thornton; L Durant; T Sparwasser; K E Webster; J Sprent; F J Culley; C Johansson; P J Openshaw
Journal:  Mucosal Immunol       Date:  2012-01-11       Impact factor: 7.313

10.  Cytochemical demonstration of hydrogen peroxide in polymorphonuclear leukocyte phagosomes.

Authors:  R T Briggs; M L Karnovsky; M J Karnovsky
Journal:  J Cell Biol       Date:  1975-01       Impact factor: 10.539

View more
  8 in total

Review 1.  From structure to redox: The diverse functional roles of disulfides and implications in disease.

Authors:  Tyler J Bechtel; Eranthie Weerapana
Journal:  Proteomics       Date:  2017-03       Impact factor: 3.984

2.  Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Authors:  Mehdi Najar; Mohammad Fayyad-Kazan; Nathalie Meuleman; Dominique Bron; Hussein Fayyad-Kazan; Laurence Lagneaux
Journal:  J Cell Commun Signal       Date:  2018-01-19       Impact factor: 5.782

3.  Insights into the Mechanisms of Lactobacillus acidophilus Activity against Entamoeba histolytica by Using Thiol Redox Proteomics.

Authors:  Lotem Sarid; Eva Zanditenas; Jun Ye; Meirav Trebicz-Geffen; Serge Ankri
Journal:  Antioxidants (Basel)       Date:  2022-04-22

4.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

5.  Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.

Authors:  Liwei Jiang; Yi-Jun Wang; Jing Zhao; Mayuko Uehara; Qingming Hou; Vivek Kasinath; Takaharu Ichimura; Naima Banouni; Li Dai; Xiaofei Li; Dale L Greiner; Leonard D Shultz; Xiaolong Zhang; Zhen-Yu Jim Sun; Ian Curtin; Nicholas E Vangos; Zoe C Yeoh; Ezekiel A Geffken; Hyuk-Soo Seo; Ze-Xian Liu; Gregory J Heffron; Khalid Shah; Sirano Dhe-Paganon; Reza Abdi
Journal:  Cell       Date:  2020-11-25       Impact factor: 41.582

6.  Structural basis for the specificity of renin-mediated angiotensinogen cleavage.

Authors:  Yahui Yan; Aiwu Zhou; Robin W Carrell; Randy J Read
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

7.  Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.

Authors:  Yu Pan; Fengchun Lu; Qinglin Fei; Xingxing Yu; Ping Xiong; Xunbin Yu; Yuan Dang; Zelin Hou; Wenji Lin; Xianchao Lin; Zheyang Zhang; Minggui Pan; Heguang Huang
Journal:  J Hematol Oncol       Date:  2019-11-27       Impact factor: 17.388

Review 8.  Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.

Authors:  Batol Abbasi; Karim Shamsasenjan; Majid Ahmadi; Seyedeh Ameneh Beheshti; Mahshid Saleh
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.